You are here

  • Home
  • Archive
  • Volume 80, Issue 1
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

Article metrics

Article menu

Download PDFPDF

XML
Recommendation
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 202011761129717
Dec 20201010990996
Jan 2021765741621
Feb 2021708692561
Mar 2021669652986
Apr 2021508491677
May 2021515503705
Jun 2021416402457
Jul 2021440422422
Aug 2021482463474
Sep 2021565539424
Oct 2021717682502
Nov 2021629568491
Dec 2021602589343
Jan 2022750742362
Feb 2022730721438
Mar 2022898890488
Apr 2022707691543
May 2022667670330
Jun 2022685670350
Jul 2022668669293
Aug 2022789782285
Sep 2022792767285
Oct 2022790774324
Nov 2022725706282
Dec 2022531517205
Jan 2023741717251
Feb 2023784754245
Mar 2023823809310
Apr 2023613592258
May 2023986960215
Jun 2023560536199
Jul 2023454444194
Aug 2023291273149
Sep 2023331292125
Oct 2023404371146
Nov 2023531486178
Dec 2023386346160
Jan 2024325247178
Feb 2024446352156
Mar 2024535510309
Apr 2024933884276
May 2024524502198
Jun 2024349307184
Jul 2024383358184
Aug 2024220197228
Sep 2024333309160
Oct 2024396378234
Nov 2024516504306
Total297982859017404